Switch to:
More From Other Websites
Amgen, Novartis Team Up; Bone Drug Positive in Phase III Sep 02 2015
Amgen, Novartis Alzheimer's Deal Gets Cautious Praise Sep 02 2015
Valeant Buys Abandoned AstraZeneca Psoriasis Drug Sep 01 2015
Insulin infusion device maker CeQur raises $100 million Sep 01 2015
Why Eli Lilly (LLY) Could Beat Earnings Estimates Again Aug 31 2015
FDA Says Certain Type 2 Diabetes Drugs Can Cause Serious Joint Pain Aug 28 2015
PRIMECAP Sells Stake in Biopharmaceutical Company Aug 28 2015
Eli Lilly's (LLY) Diabetes Drug Synjardy Gets U.S. Approval Aug 28 2015
Credit Suisse's 8 Pharmaceutical Stocks With 'Significant' Upside Aug 28 2015
Buy Eli Lilly, or Will Drug-Pricing Debate Dent the Stock? Aug 28 2015
Experimental Lilly Lung-Cancer Drug Stirs Price Debate Aug 27 2015
Oncolytics' Reolysin Phase II Lung Cancer Study Enrolled Aug 27 2015
Lilly to Participate in Morgan Stanley Global Healthcare Conference Aug 27 2015
Lilly to Participate in Morgan Stanley Global Healthcare Conference Aug 27 2015
U.S. FDA approves Synjardy® (empagliflozin/metformin hydrochloride) tablets for adults with type 2... Aug 27 2015
Coverage initiated on Eli Lilly by Berenberg Aug 27 2015
Adocia and Lilly initiate new Phase 1b study of repeated administration of ultra-rapid BioChaperone... Aug 27 2015
Eli Lilly's Alimta Patent Upheld by U.S. District Court Aug 26 2015


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK